argenx to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
04 Agosto 2020 - 2:00AM
August 4, 2020 Breda, the Netherlands /
Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX), a
global immunology company committed to improving the lives of
people suffering from severe autoimmune diseases and cancer, today
announced that Tim Van Hauwermeiren, Chief Executive
Officer, will present at the 2020 Wedbush PacGrow Healthcare
Virtual Conference on Tuesday, August 11, 2020 at 12:35 p.m.
ET.
A live webcast of the presentation will be
available on the Company’s website at www.argenx.com. A replay of
the webcast will be available for 90 days following the
presentation.
About argenxargenx is a global
immunology company committed to improving the lives of people
suffering from severe autoimmune diseases and cancer. Partnering
with leading academic researchers through its Immunology Innovation
Program (IIP), argenx is translating immunology breakthroughs into
a world-class portfolio of novel antibody-based medicines. argenx
is evaluating efgartigimod in multiple serious autoimmune diseases,
and cusatuzumab in hematological cancers in collaboration with
Janssen. argenx is also advancing several earlier stage
experimental medicines within its therapeutic franchises. argenx
has offices in Belgium, the United States and Japan. For more
information, visit www.argenx.com and follow us on LinkedIn at
https://www.linkedin.com/company/argenx/.
For further information, please contact:
Beth DelGiacco, Vice President, Investor Relations (US)+1 518
424 4980bdelgiacco@argenx.com
Joke Comijn, Director Corporate Communications & Investor
Relations (EU)+32 (0)477 77 29 44+32 (0)9 310 34
19jcomijn@argenx.com
Argen X (EU:ARGX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Argen X (EU:ARGX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024